Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

13.64
+0.61974.76%
Volume:1.20M
Turnover:15.90M
Market Cap:4.17B
PE:-30.27
High:13.64
Open:13.04
Low:12.93
Close:13.02
52wk High:13.64
52wk Low:1.01
Shares:306.00M
Float Shares:175.00M
Volume Ratio:1.10
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4506
EPS(LYR):-0.6913
ROE:-32.00%
ROA:-17.71%
PB:12.00
PE(LYR):-19.73

Loading ...

BRIEF-Erasca Announces Pricing Of Upsized Public Offering Of Common Stock

Reuters
·
Jan 22

Erasca Inc - Shares Sold at $10.00 per Share

THOMSON REUTERS
·
Jan 22

Press Release: Erasca Announces Pricing of Upsized Public Offering of Common Stock

Dow Jones
·
Jan 22

24H | Gold, Silver Stocks and ETFs Gain as Gold Tops $4,836; United Air Rises on Upbeat Outlook

Tiger Newspress
·
Jan 21

BRIEF-Erasca Announces Proposed Public Offering Of $150 Million Of Common Stock

Reuters
·
Jan 21

BUZZ-Cancer therapy firm Erasca drops after $150 mln stock offering unveil

Reuters
·
Jan 21

Erasca (ERAS) Stock Slides After The Bell: Here's Why

Benzinga
·
Jan 21

Erasca announces $150M common stock offering

TIPRANKS
·
Jan 21

Erasca posts FY cash, cash equivalents and marketable securities of USD 341.8 million

Reuters
·
Jan 21

Erasca Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 17

Erasca price target raised to $11 from $5 at Piper Sandler

TIPRANKS
·
Jan 16

Erasca Inc : Piper Sandler Raises Target Price to $11 From $5

THOMSON REUTERS
·
Jan 16

David Vs. Goliath: Why Small Caps Are Crushing The Magnificent 7

Benzinga_recent_news
·
Jan 16

Erasca rises 14.1%

TIPRANKS
·
Jan 16

Erasca Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 13

Erasca price target raised to $11 from $3 at Clear Street

TIPRANKS
·
Jan 13

BRIEF-Erasca Inc - Reports Promising Early Clinical Data For ERAS-0015

Reuters
·
Jan 12

Erasca Inc - Plans Phase 1 Data Release for Eras-0015 and Eras-4001 in 2026

THOMSON REUTERS
·
Jan 12

Erasca Inc - Reports Favorable Safety and Tolerability for Eras-0015

THOMSON REUTERS
·
Jan 12

Erasca Reports Promising Early Clinical Data for ERAS-0015 in RAS-Mutant Cancers

Reuters
·
Jan 12